….Or is it an opportunity. It’s an expensive stock and it is obvious that there is a steady decline in the last year. Is this the opportunity in the sense that the stock has a potential to gain value once again in these market conditions, or should we take our money and buy a healthcare stock that is not on the decline?
There are no replies in this thread yet. Be the first to post a reply below: